
    
      This is a multi-center, post-market, retrospective study design to collect safety and
      performance data for patients implanted with the Streamline OCT System. The study will
      include a minimum of 58 patients at a minimum of 3 sites in the United States. The study will
      enroll at a minimum of 5 subjects implanted with the occipital plate.
    
  